Seres Therapeutics, Inc.

MCRB XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

71M

Short interest (May 15)

5.3%

Net Short (Jun 03 ): 0.0%

Borrow Fee

2.29%

↑ 8.7%

Available Shares

100K

↓ 6.9%

Price Chart

Company Overview

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001609809

Asset Type: CS

Market Data

Market Cap: $70,983,236

Employees: 66

Status: Active

Short Interest

Current Borrow Fee 2.29%

Range: 2.29% - 2.78%

Available Shares 100K

Range: 80K - 100K

Recent Changes

Fee Change: ↑ 7.2%

Available Change: ↓ 7.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime